Financial Summary (All financials)
| In millions, except per share items | Apr-02-22 | Apr-03-21 | Mar-28-20 | Mar-30-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 | Mar-31-15 |
| Revenues | 1,681.1 | 1,727.6 | 1,697.0 | 1,674.5 | 856.9 | 881.2 | 856.9 | 865.0 |
| Revenue growth | -2.7% | 1.8% | 1.3% | 95.4% | -2.8% | 2.8% | -0.9% | 5.7% |
| Cost of goods sold | 995.1 | 951.1 | 1,144.8 | 980.4 | 417.8 | 439.8 | 422.2 | 403.4 |
| Gross profit | 686.1 | 776.6 | 552.2 | 694.1 | 439.1 | 441.4 | 434.7 | 461.6 |
| Gross margin | 40.8% | 44.9% | 32.5% | 41.5% | 51.2% | 50.1% | 50.7% | 53.4% |
| Selling, general and administrative | 499.8 | 488.4 | 595.5 | 567.9 | 229.4 | 223.8 | 221.3 | 229.6 |
| Research and development | 183.6 | 209.3 | 218.3 | 201.9 | 84.2 | 88.3 | 90.4 | 91.6 |
| EBIT | 2.7 | 78.9 | -261.5 | -75.6 | 125.5 | 129.2 | 123.0 | 140.4 |
| EBIT margin | 0.2% | 4.6% | -15.4% | -4.5% | 14.6% | 14.7% | 14.4% | 16.2% |
| Pre-tax income | -102.2 | -64.9 | -896.6 | -185.7 | 100.2 | 101.7 | 82.2 | 145.3 |
| Income taxes | -120.2 | -7.5 | -69.4 | -50.1 | 101.1 | 19.1 | 13.8 | 33.0 |
| Tax rate | 117.5% | 11.6% | 7.7% | 27.0% | 100.9% | 18.8% | 16.8% | 22.7% |
| Net income | 17.9 | -57.3 | -827.2 | -135.6 | -0.9 | 82.6 | 68.4 | 112.3 |
| Net margin | 1.1% | -3.3% | -48.7% | -8.1% | -0.1% | 9.4% | 8.0% | 13.0% |
| |
| Diluted EPS | $0.41 | ($1.40) | ($20.86) | ($3.61) | ($0.03) | $2.51 | $1.96 | $2.63 |
| Shares outstanding (diluted) | 43.9 | 41.0 | 39.7 | 37.6 | 32.3 | 33.0 | 34.9 | 42.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|